Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Odonate Therapeutics, Inc.
  6. News
  7. Summary
    ODTC   US6760791060

ODONATE THERAPEUTICS, INC.

(ODTC)
  Report
Delayed OTC Markets  -  05/18 09:49:31 am EDT
1.500 USD   -1.32%
05/13NORTH AMERICAN MORNING BRIEFING : Tech Futures -2-
DJ
04/12NORTH AMERICAN MORNING BRIEFING : Stocks Waver, -3-
DJ
02/22NORTH AMERICAN MORNING BRIEFING : Stocks to Open -3-
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Odonate Therapeutics Gets Nasdaq Notice to Delist Shares

01/07/2022 | 09:31am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
NASDAQ COMP. -1.72% 11779.15 Real-time Quote.-23.40%
ODONATE THERAPEUTICS, INC. -1.32% 1.5 Delayed Quote.12.59%
All news about ODONATE THERAPEUTICS, INC.
05/13NORTH AMERICAN MORNING BRIEFING : Tech Futures -2-
DJ
04/12NORTH AMERICAN MORNING BRIEFING : Stocks Waver, -3-
DJ
02/22NORTH AMERICAN MORNING BRIEFING : Stocks to Open -3-
DJ
01/20ODONATE THERAPEUTICS, INC.(NASDAQGS : ODT) dropped from S&P Global BMI Index
CI
01/20ODONATE THERAPEUTICS, INC.(NASDAQGS : ODT) dropped from S&P TMI Index
CI
01/17ODONATE THERAPEUTICS, INC.(NASDAQGS : ODT) dropped from NASDAQ Composite Index
CI
01/07Top Midday Decliners
MT
01/07Odonate Therapeutics Gets Nasdaq Notice to Delist Shares
MT
01/07ODONATE THERAPEUTICS : Delisting/Failure to Satisfy Listing Rule/Transfer of Listing - For..
PU
01/07ODONATE THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing..
AQ
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 -126 M - -
Net cash 2020 152 M - -
P/E ratio 2020 -4,99x
Yield 2020 -
Capitalization 58,5 M 58,5 M -
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 145
Free-Float 97,2%
Chart ODONATE THERAPEUTICS, INC.
Duration : Period :
Odonate Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ODONATE THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Managers and Directors
Kevin C. Tang Chairman & Chief Executive Officer
Michael S. Hearne Chief Financial Officer
Thomas Wei Chief Scientific Officer
Steven Pfeiffer Senior Vice President-Technical Operations
Kimberly Ma Senior Vice President-Clinical Operations
Sector and Competitors
1st jan.Capi. (M$)
ODONATE THERAPEUTICS, INC.12.59%59
JOHNSON & JOHNSON4.53%470 547
PFIZER, INC.-13.06%288 063
ABBVIE INC.14.31%273 513
ELI LILLY AND COMPANY9.12%271 308
ROCHE HOLDING AG-14.97%263 868